Evidence map›Paper›PMID 39060285›Full record

ArticleNPJ Parkinson's disease2024

Characterizing a complex CT-rich haplotype in intron 4 of SNCA using large-scale targeted amplicon long-read sequencing.

Pilar Alvarez Jerez, Kensuke Daida, Francis P Grenn, Laksh Malik, Abigail Miano-Burkhardt, Mary B Makarious, Jinhui Ding, J Raphael Gibbs, Anni Moore, Xylena Reed and 12 more

Abstract read
In one paragraph

Article in NPJ Parkinson's disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Pilar Alvarez JerezLaboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA.
Kensuke DaidaLaboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-9177-9587
Francis P GrennLaboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA.
Laksh MalikCenter for Alzheimer's and Related Dementias, National Institute on Aging, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-2498-146X
Abigail Miano-BurkhardtLaboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-0447-4698
Mary B MakariousLaboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-7978-1051
Jinhui DingLaboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA.
J Raphael GibbsLaboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-6985-0658
Anni MooreLaboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA.
Xylena ReedCenter for Alzheimer's and Related Dementias, National Institute on Aging, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-7563-9365
Mike A NallsLaboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA.ORCID http://orcid.org/0000-0003-0319-4325
Syed ShahDataTecnica LLC, Washington, DC, USA.ORCID http://orcid.org/0000-0002-2094-3386
Medhat MahmoudHuman Genome Sequencing Center, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA.
Fritz J SedlazeckHuman Genome Sequencing Center, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA.ORCID http://orcid.org/0000-0001-6040-2691
Egor DolzhenkoPacific Biosciences, Menlo Park, CA, USA.
Morgan ParkNIH Intramural Sequencing Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
Hirotaka IwakiLaboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-8982-7885
Bradford CaseyThe Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA.ORCID http://orcid.org/0000-0002-2623-5997
Mina RytenGenetics and Genomic Medicine, Great Ormond Street Institute of Child Health, University College London, London, UK.ORCID http://orcid.org/0000-0001-9520-6957
Cornelis BlauwendraatLaboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA.ORCID http://orcid.org/0000-0001-9358-8111
Andrew B SingletonLaboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA.
Kimberley J BillingsleyLaboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA. kimberley.billingsley@nih.gov.ORCID http://orcid.org/0000-0002-8003-4029

Funding

Harmonized Data-Derived Resources for the Alzheimer's Disease and Related Dementias CommunityZIAAG000534 · NIA · NATIONAL INSTITUTE ON AGING · PI COOKSON, MARK · 2019 to 2025
$85.1M
Long-read DNA sequencing of Alzheimers Disease and Related Dementias casesZIAAG000538 · NIA · NATIONAL INSTITUTE ON AGING · PI COOKSON, MARK · 2020 to 2025
$39.6M
University of Kentucky Alzheimer's Disease Research CenterP30AG072946 · NIA · UNIVERSITY OF KENTUCKY · PI LINDA J VAN ELDIK · 2021 to 2026
$23.5M
Genetic characterization of atypical parkinsonismZIANS003154 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI SCHOLZ, SONJA · 2016 to 2025
$15.4M
Assessment of Candidate Loci in Neurological diseasesZIAAG000957 · NIA · NATIONAL INSTITUTE ON AGING · PI SINGLETON, ANDREW · 2009 to 2024
$12.2M
Genome wide SNP analysis in Parkinson's diseaseZ01AG000949 · NIA · NATIONAL INSTITUTE ON AGING · PI SINGLETON, ANDREW B · 2006 to 2008
$2.6M
MIDCAREER AWARD IN PATIENT ORIENTED RESEARCH ON AGINGK24AG000949 · NIA · YALE UNIVERSITY · PI INOUYE, SHARON K. · 1999 to 2009
$1.4M
Prospective studies on Parkinson's diseaseZ01ES101986 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI CHEN, HONGLEI · 2006 to 2008
$1.2M
Intramural NIH HHS Z01 AG000949Intramural NIH HHS Z01 ES101986Intramural NIH HHS ZIA AG000534Intramural NIH HHS ZIA NS003154NIA NIH HHS K24 AG000949NIA NIH HHS P30 AG072946
6 · The paper itself

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder with a significant risk proportion driven by genetics. While much progress has been made, most of the heritability remains unknown. This is in-part because previous genetic studies have focused on the contribution of single nucleotide variants. More complex forms of variation, such as structural variants and tandem repeats, are already associated with several synucleinopathies. However, because more sophisticated sequencing methods are usually required to detect these regions, little is understood regarding their contribution to PD. One example is a polymorphic CT-rich region in intron 4 of the SNCA gene. This haplotype has been suggested to be associated with risk of Lewy Body (LB) pathology in Alzheimer's Disease and SNCA gene expression, but is yet to be investigated in PD. Here, we attempt to resolve this CT-rich haplotype and investigate its role in PD. We performed targeted PacBio HiFi sequencing of the region in 1375 PD cases and 959 controls. We replicate the previously reported associations and a novel association between two PD risk SNVs (rs356182 and rs5019538) and haplotype 4, the largest haplotype. Through quantitative trait locus analyzes we identify a significant haplotype 4 association with alternative CAGE transcriptional start site usage, not leading to significant differential SNCA gene expression in post-mortem frontal cortex brain tissue. Therefore, disease association in this locus might not be biologically driven by this CT-rich repeat region. Our data demonstrates the complexity of this SNCA region and highlights that further follow up functional studies are warranted.

Identifiers

PMID39060285
PMCPMC11282088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.